A prediction-based approach to the analysis of data from randomized clinical trials is implemented. Based on response and covariate data from a randomized clinical trial comparing a new experimental treatment E versus a control C, the objective is to develop and internally validate a model that can identify subjects likely to benefit from E rather than C. Currently, survival and binary response types are permitted.
